Skip to main content
SpringerLink
Log in

Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Cerebral amyloid angiopathy is a disorder in which deposition of amyloid within the arterial media and adventitia leads to intracerebral hemorrhage. Diagnosis during life has been hampered by the requirement for post-mortem examination for definitive diagnosis. The Boston Criteria for the diagnosis of cerebral amyloid angiopathy-related hemorrhage were developed in 1995 and 1996 in order to meet the need for a standardized set of diagnostic criteria that can be applied to living patients. Using a combination of clinical, radiologic, and pathologic data, these criteria reliably differentiate lobar intracerebral hemorrhage into categories of possible, probable, or definite based on the likelihood of underlying cerebral amyloid angiopathy. These criteria will be crucial for disease classification for future clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Vinters HV, Gilbert JJ: Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983, 14:924–928.

    PubMed  CAS  Google Scholar 

  2. Rosand J, Hylek EM, O’Donnell HC, Greenberg SM: Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 2000, 55:947–951.

    PubMed  CAS  Google Scholar 

  3. Greenberg SM, Rebeck GW, Vonsattel JP, et al.: Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995, 38:254–259.

    Article  PubMed  CAS  Google Scholar 

  4. Greenberg SM, Briggs ME, Hyman BT, et al.: Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996, 27:1333–1337.

    PubMed  CAS  Google Scholar 

  5. Gilbert JJ, Vinters HV: Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983, 14:915–923.

    PubMed  CAS  Google Scholar 

  6. Vinters HV: Cerebral amyloid angiopathy. A critical review. Stroke 1987, 18:311–324.

    PubMed  CAS  Google Scholar 

  7. Ellis RJ, Olichney JM, Thal LJ, et al.: Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 1996, 46:1592–1596.

    PubMed  CAS  Google Scholar 

  8. Levy E, Carman MD, Fernandez-Madrid IJ, et al.: Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248:1124–1126.

    Article  PubMed  CAS  Google Scholar 

  9. Grabowski TJ, Cho HS, Vonsattel JP, et al.: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001, 49:697–705.

    Article  PubMed  CAS  Google Scholar 

  10. Greenberg SM, Vonsattel JP: Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 1997, 28:1418–1422.

    PubMed  CAS  Google Scholar 

  11. Masuda J, Tanaka K, Ueda K, Omae T: Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988, 19:205–210.

    PubMed  CAS  Google Scholar 

  12. Greenberg SM, Vonsattel JP, Segal AZ, et al.: Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998, 50:961–965.

    PubMed  CAS  Google Scholar 

  13. McCarron MO, Nicoll JA: High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci Lett 1998, 247:45–48.

    Article  PubMed  CAS  Google Scholar 

  14. Nicoll JA, Burnett C, Love S, et al.: High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997, 41:716–721.

    Article  PubMed  CAS  Google Scholar 

  15. McCarron MO, Nicoll JA, Stewart J, et al.: The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999, 58:711–718.

    PubMed  CAS  Google Scholar 

  16. Premkumar DR, Cohen DL, Hedera P, et al.: Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol 1996, 148:2083–2095.

    PubMed  CAS  Google Scholar 

  17. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM: Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998, 57:353–359.

    PubMed  CAS  Google Scholar 

  18. O’Donnell HC, Rosand J, Knudsen KA, et al.: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000, 342:240–245.

    Article  PubMed  CAS  Google Scholar 

  19. Kase CS: Lobar hemorrhage. In Intracerebral Hemorrhage. Edited by Kase CS, Caplan LR. Boston: Butterworth-Heinemann; 1994:363–382.

    Google Scholar 

  20. Itoh Y, Yamada M, Hayakawa M, et al.: Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993, 116:135–141.

    Article  PubMed  CAS  Google Scholar 

  21. Cuny E, Loiseau H, Rivel J, et al.: Amyloid angiopathy-related cerebellar hemorrhage. Surg Neurol 1996, 46:235–239.

    Article  PubMed  CAS  Google Scholar 

  22. Yamada M, Itoh Y, Otomo E, et al.: Subarachnoid haemorrhage in the elderly: a necropsy study of the association with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 1993, 56:543–547.

    Article  PubMed  CAS  Google Scholar 

  23. Ropper AH, Davis KR: Lobar cerebral hemorrhages: acute clinical syndromes in 26 cases. Ann Neurol 1980, 8:141–147.

    Article  PubMed  CAS  Google Scholar 

  24. Schutz H, Bodeker RH, Damian M, et al.: Age-related spontaneous intracerebral hematoma in a German community. Stroke 1990, 21:1412–1418.

    PubMed  CAS  Google Scholar 

  25. Helweg-Larsen S, Sommer W, Strange P, et al.: Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke 1984, 15:1045–1048.

    PubMed  CAS  Google Scholar 

  26. Broderick JP, Brott TG, Duldner JE, et al.: Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality [comment]. Stroke 1993, 24:987–993.

    PubMed  CAS  Google Scholar 

  27. Kase CS, Williams JP, Wyatt DA, Mohr JP: Lobar intracerebral hematomas: clinical and CT analysis of 22 cases. Neurology 1982, 32:1146–1150.

    PubMed  CAS  Google Scholar 

  28. Massaro AR, Sacco RL, Mohr JP, et al.: Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank [comment]. Neurology 1991, 41:1881–1885.

    PubMed  CAS  Google Scholar 

  29. Juvela S: Risk factors for impaired outcome after spontaneous intracerebral hemorrhage [comment]. Arch Neurol 1995, 52:1193–1200.

    PubMed  CAS  Google Scholar 

  30. Bailey RD, Hart RG, Benavente O, Pearce LA: Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001, 56:773–777.

    PubMed  CAS  Google Scholar 

  31. Greenberg SM, Vonsattel JP, Stakes JW, et al.: The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993, 43:2073–2079.

    PubMed  CAS  Google Scholar 

  32. Olichney JM, Hansen LA, Hofstetter CR, et al.: Cerebral infarction in Alzheimer’s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995, 52:702–708.

    PubMed  CAS  Google Scholar 

  33. Cadavid D, Mena H, Koeller K, Frommelt RA: Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000, 59:768–773.

    PubMed  CAS  Google Scholar 

  34. Okazaki H, Reagan TJ, Campbell RJ: Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979, 54:22–31.

    PubMed  CAS  Google Scholar 

  35. Imaoka K, Kobayashi S, Fujihara S, et al.: Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study. J Neurol 1999, 246:661–666.

    Article  PubMed  CAS  Google Scholar 

  36. Gray F, Dubas F, Roullet E, Escourolle R: Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985, 18:54–59.

    Article  PubMed  CAS  Google Scholar 

  37. Roullet E, Gray FF: Leuko-araiosis in severe amyloid angiopathy. Arch Neurol 1988, 45:140.

    PubMed  CAS  Google Scholar 

  38. Fountain NB, Eberhard DA: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature [comment]. Neurology 1996, 46:190–197.

    PubMed  CAS  Google Scholar 

  39. Osumi AK, Tien RD, Felsberg GJ, Rosenbloom M: Cerebral amyloid angiopathy presenting as a brain mass. Am J Neuroradiol 1995, 16:911–915.

    PubMed  CAS  Google Scholar 

  40. Spaar FW, Goebel HH, Volles E, Wickboldt J: Tumor-like amyloid formation (amyloidoma) in the brain. J Neurol 1981, 224:171–182.

    Article  PubMed  CAS  Google Scholar 

  41. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al.: Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991, 30:637–649.

    Article  PubMed  CAS  Google Scholar 

  42. Greenberg SM, Finklestein SP, Schaefer PW: Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 1996, 46:1751–1754.

    PubMed  CAS  Google Scholar 

  43. Greenberg SM, O’Donnell HC, Schaefer PW, Kraft E: MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999, 53:1135–1138.

    PubMed  CAS  Google Scholar 

  44. Greenberg SM, Rosand J: Outcome markers for clinical trials in cerebral amyloid angiopathy. Amyloid 2001, 8:56–60.

    PubMed  Google Scholar 

  45. McCarron MO, Nicoll JA: APOE genotype in relation to sporadic and Alzheimer-related CAA. In Cerebrovascular Amyloidosis in Alzheimer’s Disease and Related Disorders. Edited by Verbeek MN, Vinters HV, de Waal RMV. Dordrecht, Netherlands: Wolters Kluwer; 2000.

    Google Scholar 

  46. Greenberg SM: Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998, 51:690–694.

    PubMed  CAS  Google Scholar 

  47. Knudsen KA, Rosand J, Karluk D, Greenberg SM: Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001, 56:537–539.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Clinical Trials Unit, Wang 836, Massachusetts General Hospital, 55 Fruit Street, 02114, Boston, MA, USA

    Eric E. Smith MD & Steven M. Greenberg MD, PhD

Authors
  1. Eric E. Smith MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven M. Greenberg MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, E.E., Greenberg, S.M. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria. Curr Atheroscler Rep 5, 260–266 (2003). https://doi.org/10.1007/s11883-003-0048-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-003-0048-4

Keywords

Search

Navigation